conference logo
 
Programme  Titles  Presenters  Topics 
Embryonal Tumors
Sunday, July 1, 11:30am - 12:30pm

 

SESSION CHAIRS: Annie Huang, Dominik Sturm

 


EMBR-05 Tumors of the pineal region can be classified into distinct subgroups based on molecular characteristics correlating with clinical parameters and genetic alterations
Elke Pfaff*1,2, Matija Snuderl3,4, Matthias A. Karajannis5, Christian Aichmüller6, Martin Sill7, Brent A. Orr8, David W. Ellison9, Stefan M. Pfister1,2, David T.W. Jones1
1Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ) and Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Germany, 2Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Germany, 3Division of Neuropathology and Department of Neurology, NYU Langone Medical Center, USA, 4Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, USA, 5Department of Pediatrics, Memorial Sloan Kettering Cancer Center, USA, 6Division of Molecular Genetics, German Cancer Research Center (DKFZ), Germany, 7Division of Biostatistics, German Cancer Research Center (DKFZ), Germany, 8Department of Pathology, St. Jude Children's Research Hospital, USA, 9Department of Oncology, St. Jude Children's Research Hospital, USA
EMBR-10 Genomic complexity and evolution of Embryonal Tumors with Multilayered Rosettes (ETMR)
Sander Lambo1,2, Sebastian M. Waszak3, Tobias Rausch3, Susanne Groebner1,2, Christin Schmidt1,2, Sebastian Brabetz1,2, Stefan M. Pfister1,2, Andrey Korshunov2, Marcel Kool*1,2
1Hopp Children's Cancer center at the NCT Heidelberg (KiTZ), Germany, 2German Cancer Research Center (DKFZ), Germany, 3European Molecular Biology Laboratory, Genome Biology Unit, Germany
EMBR-17 Pineoblastoma segregates into molecular subtypes with distinct clinicopathologic features: report from the Rare Brain Tumor Consortium
Bryan Li*1,2, Alexandre Vasiljevic3,4, Ben Ho1, Joseph Norman1, Mei Lu1, Eugene Hwang5, Jordan Hansford6, Anne Jouvet4,7, Annie Laquerriere8, Marie-Bernadette Delisle9, Sridharan Gururangan10, Jason Fangusaro11, Fabien Forest12, Nobusawa Sumihito13, Helen Toledano14, Diane Birks15, Xing Fan16, Maryam Fouladi17, Amar Gajjar18, Guillaume Gauchotte19, Lindsey Hoffman15, Chris Jones20, Delphine Loussouarn21, Karima Mokhtari22, Scott Pomeroy23, Audrey Rousseau24, Gino Somers25, Michael Taylor26, David Ziegler27, Cynthia Hawkins25, Eric Bouffet28, Richard Grundy29, Christelle Dufour30, Annie Huang1,2
1Arthur and Sonia Labatt Brain Tumour Research Centre, Division of Hematology/Oncology, The Hospital for Sick Children, Canada, 2Laboratory Medicine and Pathobiology, University of Toronto, Canada, 3Faculté de Médecine, Université de Lyon, France, 4CHU de Lyon, France, 5Department of Oncology, Children’s National Medical Center, USA, 6Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, Australia, 7Pathology & Molecular Biology, SFCE, France, 8Department of Pathology, Rouen University Hospital, France, 9CHU de Toulouse, Hôpital Ranguei, France, 10Lillian S. Well Dept of Neurosurgery, University of Florida, USA, 11Division of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ann and Robert H. Lurie Children’s Hospital of Chicago, USA, 12Department of Pathology, CHU St. Etienne, France, 13Department of Human Pathology, Gunma University, Japan, Japan, 14Department of Pediatric Hematology Oncology, Children’s Medical Center of Israel, Israel, 15Department of Pediatrics, University of Colorado Denver, USA, 16Department of Neurosurgery, University of Michigan, USA, 17Division of Oncology, Cincinnati Children's Hospital Medical Center, USA, 18Department of Oncology, Division of Neuro-Oncology, St. Jude Children's Research Hospital, USA, 19Department of Pathology, CHU Nancy, France, 20The Institute of Cancer Research, UK, 21Service d'Anatomie et de Cytologie pathologiques, CHU Nantes, France, 22Département de Neuropathologie, Hôpital Universitaire Pitie-Salpetriere, France, 23F.M. Kirby Neurobiology Center, Boston Children's Hospital, USA, 24Département de Pathologie cellulaire et tissulaire, CHU d'Angers, France, 25Arthur and Sonia Labatt Brain Tumour Research Centre, Division of Pathology, The Hospital for Sick Children, Canada, 26Arthur and Sonia Labatt Brain Tumour Research Centre, Division of Neurosurgery, The Hospital for Sick Children, Canada, 27Kids Cancer Centre, Sydney Children's Hospital, Australia, 28Division of Hematology/Oncology, The Hospital for Sick Children, Canada, 29Faculty of Medicine & Health Sciences, University of Nottingham, UK, 30Département de Cancérologie de l'Enfant et de l'Adolescent, Institut Gustave Roussy, France
TBIO-18 Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell free DNA in peripheral blood, CSF, and urine
Melanie Pages*1, Denisse Rotem2, Gregory Gydush2, Sarah Reed2, Justin Rhoades2, Gavin Ha2, Chris Lo2, Adam Tracy2, Robert Jones1, Sarah Becker1, Michaela Haller1, Susan Chi1,3, Mark Kieran1,3, Liliana Goumnerova1,3, J Christopher Love4, Keith L Ligon1,3, Pratiti Bandopadhayay1,3, Karen Wright1,3, Viktor A Adalsteinsson2,4, Rameen Beroukhim1,2
1Dana-Farber Cancer Institute/Boston Children’s Cancer and Blood Disorders Center, USA, 2Broad Institute, USA, 3Boston Children's Hospital, USA, 4Massachusetts Institute of Technology, USA
TBIO-20 Clinical tumor whole exome sequencing for pediatric neuro-oncology patients – results from the Baylor Advancing Sequencing in Childhood Cancer Care (BASIC3) clinical sequencing study
Frank Lin*1,2, Samara Potter1,2, Michelle Ting1,2, Raghu Chandramohan1, Nipun Kakkar1, Tao Wang1, Robin Raesz-Martinez2, Sarah Scollon1,2, Katie Bergstrom1,2, Dolores Lopez-Terrada1,2, Adekunle Adesina1,2, Carrie Mohila1,2, William Whitehead1,2, Uma Ramamurthy1, Susan Hilsenbeck1, David Wheeler1, Stacey Berg1,2, Murali Chintagumpala1,2, Christine Eng1, Richard Gibbs1, Angshumoy Roy1,2, Sharon Plon1,2, D. Williams Parsons1,2
1Baylor College of Medicine, USA, 2Texas Children's Cancer Center, USA